Chiropractors in Athens, PA Accepting Medicare

8 Chiropractors found. Showing 1 - 8

Dr. Karyn L Ross Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 203 South St Ste D, Athens, PA 18810 Phone: 570-888-0443    Fax: 570-888-0437

Dr. Karyn Lynne Ross, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 203 South St # D, Athens, PA 18810 Phone: 570-888-0443    Fax: 570-888-0437

Trey Hildebrandt, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 29767 Route 220, Athens, PA 18810 Phone: 570-882-9009

Nbdtmh Dc Pllc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 29767 Route 220, Athens, PA 18810 Phone: 570-882-9009    Fax: 570-882-9011

Dr. Eric C Etka, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 224 S Main St, Athens, PA 18810 Phone: 570-882-8081    Fax: 570-888-4998

Dr. Thomas Raymond Horn, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 27811 Route 220, Athens, PA 18810 Phone: 570-882-9009    Fax: 570-882-9011

Chiropractic Family Wellness Center Chiropractor Medicare: Medicare Enrolled Practice Location: 27811 Route 220, Athens, PA 18810 Phone: 570-882-9009    Fax: 570-882-9011

Dr. Nathaniel Brennan Callear, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 27811 Route 220, Athens, PA 18810 Phone: 570-882-9009    Fax: 570-882-9011

News Archive

Earlier hormone therapy trial scared women - but it was wrong!

According to new research the widely publicised 2002 study which apparently proved that hormone replacement therapy raised the risk of heart disease and breast cancer, was fundamentally flawed.

AVANIR Pharmaceuticals announces results of Zenvia double-blind Phase III STAR trial

AVANIR Pharmaceuticals, Inc. today announced detailed results from the confirmatory double-blind Phase III STAR trial evaluating two doses of the investigational drug Zenvia™ (dextromethorphan/quinidine) compared to placebo in the treatment of pseudobulbar affect (PBA) in patients with underlying multiple sclerosis (MS) or amyotrophic lateral sclerosis (ALS).

FDA supports new Hepatitis C drug from Vertex Pharmaceuticals

Vertex pharmaceuticals jumped 10 percent in value on the Nasdaq after U.S. regulators FDA said the company's experimental hepatitis C drug cures more patients than current therapies.

Accidental deaths among kids down but more needs to be done: CDC report

According to U.S. mortality data the overall death rate from unintentional injury among children and teens fell 29% from 2000 to 2009. What was concerning however, was that rates of death by poisoning in young adults - mostly from prescription drug overdose - and suffocation in infants rose. And unintentional injury still accounted for 37% of all deaths in the 19-and-under age group in 2009 and was the fifth leading killer of patients younger than 1, the report said. The CDC report was published in the April 16 issue of Morbidity and Mortality Weekly Report.

Study elucidates potential benefits of antiarrhythmic drugs for out-of-hospital cardiac arrest patients

Paramedics often give heart rhythm stabilizing drugs to patients who are suffering out-of-hospital cardiac arrest when they fail to regain a stable heart rhythm after electrical shock treatment.

Read more Medical News

› Verified 1 days ago